tradingkey.logo
tradingkey.logo
Search

Co-Diagnostics Inc

CODX
Add to Watchlist
2.990USD
-0.090-2.92%
Close 07/02, 13:00ETQuotes delayed by 15 min
10.77MMarket Cap
LossP/E TTM

More Details of Co-Diagnostics Inc Company

Co-Diagnostics, Inc. is a molecular diagnostics company, which develops, manufactures and markets diagnostics technologies. The Company’s technologies are utilized for tests that are designed using the detection and/or analysis of nucleic acid molecules (DNA or RNA). The Company also uses its proprietary technology to design specific tests for its Co-Dx PCR platform and to locate genetic markers for use in applications other than infectious disease. Its diagnostics systems enable dependable, low-cost, molecular testing for organisms and genetic diseases by automating or simplifying historically complex procedures in both the development and administration of tests. It is developing a portable diagnostic device and test system designed for point-of-care and at-home use. The system consists of its PCR instrument that it refers to as the Co-Dx PCR Pro instrument, its proprietary diagnostic test cup system and a mobile application to be installed on the user’s mobile device.

Co-Diagnostics Inc Info

Ticker SymbolCODX
Company nameCo-Diagnostics Inc
IPO dateJul 12, 2017
CEOEgan (Dwight H)
Number of employees132
Security typeOrdinary Share
Fiscal year-endJul 12
Address2401 S. Foothill Dr. Suite D
CitySALT LAKE CITY
Stock exchangeNASDAQ OMX - NASDAQ BASIC
CountryUnited States of America
Postal code84109
Phone18014381036
Websitehttps://codiagnostics.com/
Ticker SymbolCODX
IPO dateJul 12, 2017
CEOEgan (Dwight H)

Company Executives of Co-Diagnostics Inc

Name
Name/Position
Position
Shareholding
Change
Mr. Richard S. Serbin
Mr. Richard S. Serbin
Independent Director
Independent Director
12.45K
+13.62%
Mr. James B. Nelson
Mr. James B. Nelson
Independent Director
Independent Director
12.36K
+13.71%
Mr. Dwight H. Egan
Mr. Dwight H. Egan
Chairman of the Board, President, Chief Executive Officer
Chairman of the Board, President, Chief Executive Officer
--
--
Dr. Eugene Durenard, Ph.D.
Dr. Eugene Durenard, Ph.D.
Independent Director
Independent Director
--
--
Mr. Edward L. (Ted) Murphy
Mr. Edward L. (Ted) Murphy
Independent Director
Independent Director
--
--
Mr. Brian L. Brown, CPA
Mr. Brian L. Brown, CPA
Chief Financial Officer, Company Secretary
Chief Financial Officer, Company Secretary
--
--
Mr. Richard Abbott
Mr. Richard Abbott
President
President
--
--
Name
Name/Position
Position
Shareholding
Change
Mr. Richard S. Serbin
Mr. Richard S. Serbin
Independent Director
Independent Director
12.45K
+13.62%
Mr. James B. Nelson
Mr. James B. Nelson
Independent Director
Independent Director
12.36K
+13.71%
Mr. Dwight H. Egan
Mr. Dwight H. Egan
Chairman of the Board, President, Chief Executive Officer
Chairman of the Board, President, Chief Executive Officer
--
--
Dr. Eugene Durenard, Ph.D.
Dr. Eugene Durenard, Ph.D.
Independent Director
Independent Director
--
--
Mr. Edward L. (Ted) Murphy
Mr. Edward L. (Ted) Murphy
Independent Director
Independent Director
--
--
Mr. Brian L. Brown, CPA
Mr. Brian L. Brown, CPA
Chief Financial Officer, Company Secretary
Chief Financial Officer, Company Secretary
--
--

FAQs

Who are the top five shareholders of Co-Diagnostics Inc?

The top five shareholders of Co-Diagnostics Inc are: Mr. Richard S. Serbin

How many institutions hold shares of Co-Diagnostics Inc (CODX)?

As of 2026Q1, 75 institutions hold shares of Co-Diagnostics Inc, with a combined market value of approximately 248.15K, accounting for 6.89% of the total shares. Compared to 2025Q4, institutional shareholding has increased by -158736.00.